Business Wire

Shippeo Advances Multimodal Transport Visibility Platform With New Autumn Platform Release, Announces Searoutes Partnership for Precise Carbon Emissions Tracking

Share

Shippeo, a leading provider of global and multimodal shipment visibility, announced major platform enhancements as part of their feature-packed 2022 Autumn platform release at their Visibility Now! event in Paris. The update brings a range of new, disruptive capabilities to their Ocean Visibility solution, higher accuracy carbon emissions calculations powered by specialist Searoutes, and a range of general enhancements aimed at boosting data quality, usability and supply chain ecosystem collaboration.

“We know that supply chain resiliency is top of mind for supply chain executives and that dynamic operational visibility is foundational for resilience,” explains Anand Medepalli, Chief Product Officer at Shippeo. “Our latest platform release brings a range of exciting features and capabilities, arming organizations with the tools and knowledge to make quicker decisions, mitigate disruptions and collaborate with trading partners in real time, so that supply chain actors can design, plan and run the most profitable, sustainable and resilient supply chains.”

“The enormous challenges and uncertainty around ocean shipping, and growing internal and external pressures for businesses to operate more sustainably, are key drivers for the exciting innovations we’re introducing in our Autumn release, delivering significant value for our customers. We know that Shippeo’s value comes from us being a reliable visibility platform with a strong carrier network delivering high quality visibility data and meaningful insights with an intuitive user experience. These are precisely the areas our product team focused on in 2022.”

Major enhancements to Ocean Visibility platform including a new Port Insights engine

Shippeo’s latest Ocean Visibility solution updates provide customers with more useful, higher-quality ocean transport data, thanks to a new tech architecture supporting data quality and scalability improvements, making it possible to track an unlimited number of containers across multiple data sources. In addition, new dashboards provide powerful insights to aid in contract negotiations with carriers.

Enhanced demurrage and detention analytics down to a port pair level make it easier to identify and proactively react to affected containers. New Lane Insights highlight lead time, punctuality, transshipment duration, and more, offering new network analysis tools for shippers. Shippers can identify weak spots, such as ports or carriers experiencing frequent delays, and access lane analysis for specific routes.

Port Insights provides shippers with a better understanding of congestion and efficiency at ports throughout the world. In addition, by drawing on Shippeo’s multi-year research into ETA algorithms and geofencing technology, users benefit from best-in-class vessel ETAs, promising significant accuracy improvements over those provided by shipping lines. Through combining historical data with live AIS satellite data, terrestrial data and vessel schedule data, Shippeo’s Port Insights engine generates more accurate arrival and departure events at marine ports, resulting in the highest fidelity visibility of journeys and milestones for any shipment.

“We believe our Ocean Visibility platform offers the most accurate view available of what’s happening for any port on the planet,” says Medepalli. “With insights on more than 3000 ports worldwide, we offer customers a more complete and accurate understanding of their vessel routes. Along with our enhanced Demurrage and Detention dashboard, Lane Insights and best-in-class vessel ETA algorithm, our latest ocean product update is a disruptive, market-leading solution. And, as it is built on the same platform as our Road, Air and Rail Visibility solutions, we can help track multimodal shipments, regardless of which modes are used.”

New Searoutes partnership for reliable, global CO2 emission calculations

Shippeo’s Carbon Visibility product takes granular shipment level data, including routes, mileage, and more, to estimate carbon emissions attributable to road, ocean, inland waterway, rail and air shipments. A new platform integration with specialist carbon emissions estimating company Searoutes now allows accredited, higher quality carbon, and other greenhouse gas-equivalent emissions calculations across all transport modes in a single platform.

Searoutes also offers the unique benefit of modeled calculations for both milk-runs over road, and for ocean shipments. Advanced algorithms and a more detailed analysis, mean emissions are now less likely to be overstated and insights are more actionable.

“By combining Shippeo’s high quality data and Searoutes’s state-of-the-art models, our platform offers a unique and powerful Carbon Visibility solution to help our customers run sustainable supply chains,” explains Medepalli. “Our approach to carbon reporting simplifies effort for shippers and carriers by combining analysis across all modes in a single platform, and makes it possible to review carbon footprint at different levels of granularity, such as by region or business unit.”

Searoutes CEO, Pierre Garreau, expresses his delight about the partnership. “Searoutes was founded to find ways to use the latest data modeling and AI to solve the dual challenge of lowering fuel consumption and carbon emissions in one of the biggest contributing sectors to climate change; transportation,” says Garreau. “Today, Shippeo offers the best visibility data stewardship out there, so the mix of their excellent data quality with top-notch greenhouse gas emissions modeling from Searoutes will give customers the ability to have extremely accurate emissions reporting to help figure out a baseline for determining the best supply chain strategy, as they navigate an increasingly regulated shipping landscape.”

Platform innovations boosting data quality, usability and supply chain ecosystem collaboration

Along with Ocean and Carbon Visibility solution enhancements, Shippeo has introduced a number of other platform updates to propel its category-leading data intelligence capabilities even further. It’s now easier to detect broken telematics units with Shippeo platform’s unique Smart Tracking Analyzer, a tool which analyzes root-causes of low tracking rates and prescribes actions for users to remedy them. In addition, it’s now possible for users to update transport orders and add milestone events, such as multiple delivery attempts, even after transportation has finished, so that recorded information can be made more accurate, contributing to overall quality of visibility data.

In parallel, a new Notifications Builder offers platform users the ability to fully configure, customize and white label notifications. With a simple UI, the tool introduces greater flexibility for new ways to communicate and collaborate with ecosystem partners.

Watch Shippeo’s full autumn platform release announcement

About Searoutes
Searoutes specializes in innovative digital solutions for sustainability within the sea, air and logistics sector. The company is rooted in its proprietary routing algorithms that use historical ship data collected from AIS signals that allow for greater accuracy through superior methodologies. Today, Searoutes has developed a comprehensive collection of APIs to search, report and plan on real-time routes and CO2 emissions for all modes of transport to facilitate the decarbonization of freight transport.

About Shippeo
Shippeo is a global leader in real-time multimodal transportation visibility, helping major shippers and logistics service providers operate more collaborative, automated, sustainable, profitable, and customer-centric supply chains. This is made possible with highly accurate, real-time operational visibility and perfect workflow orchestration. Their Multimodal Visibility Network integrates with more than 875 TMS, telematics and ELD systems, enabling Shippeo’s platform to provide instant access to real-time shipment tracking across all transport modes, in a single portal, through an intuitive user experience. A proprietary and industry-leading machine learning algorithm offers unmatched ETA accuracy, allowing supply chain companies to quickly anticipate problems, proactively alert customers, efficiently manage exceptions with collaborative workflows, and accurately measure CO2 and GHG emissions from supply chain transport. Hundreds of customers, including global brands like Coca-Cola HBC, Carrefour, Renault Group, Schneider Electric, Total, Siemens Energy, Faurecia, Saint-Gobain and Eckes Granini, trust Shippeo to track more than 28 million shipments per year across 95 countries. Learn more at www.shippeo.com

LinkedIn, Facebook, Twitter

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Daria Sainani, Head of Growth Marketing, Shippeo
tel. +33 6 7620 3772, email: daria.sainani@shippeo.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press Release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press Release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press Release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye